Gavin Braithwaite

CEO | Cambridge Polymer Group

Gavin Braithwaite is CEO of Cambridge Polymer Group, leading day‑to‑day operations and strategic direction while remaining hands‑on in project work. With almost 30 years at CPG he has worked on projects ranging from material development through to root-cause determination. He has authored publications on atomic force microscopy; measurement and modification of native tissue; hyaluronic acid in viscosupplementation; hydrogels for tissue spacers, cartilage and cardiovascular applications; and thermoplastics in orthopaedics. He holds multiple patents spanning hydrogels, biomedical materials and devices, and instrumentation.

All Sessions by Gavin Braithwaite

May 27, 2026

Cambridge Polymer Group: Smarter Polymer Selection for Safer, More Effective Medical Devices
2:30 PM - 3:20 PM
259 B

Polymers have been used in medical devices since the early 20th century. Their unique combination of manufacturability, strength-to-weight ratio, cost, and biocompatibility drives their use in products ranging from permanent implants to surgical tools and robotics, but these strengths come with inherent risks. This panel will explore the complexities of material selection, regulatory clearance, and long-term performance. We will specifically address challenges in biocompatibility, sterilization, aging, and environmental impact, teaching attendees how to identify hidden material risks and avoid costly assumptions early in the design process.

Share

Gavin Braithwaite
Topics
When
Sunday to Wednesday
December 23 to 26, 2022
Where
467 Davidson ave
Los Angeles CA 95716